Stock Screener App

Frei -

Installieren

51.78

0.19% -0.10

Akero Therapeutics Inc (AKRO)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt AKRO? Forum Prognose

Finanzdaten der Akero Therapeutics Inc-Aktie (AKRO)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Research and Development	5.14% 50.65	53.39	38.63	27.98	21.79
Interest Income/Expense	10.48% 0.991	0.897	0.888	0.857	0.457
Operating Income/Loss	3.10% -59.95	-61.87	-46.62	-35.63	-28.75
Income/Loss From Continuing Operations Before Tax	3.34% -53.34	-55.19	-39.66	-31.08	-25.83
Income/Loss From Continuing Operations After Tax	3.34% -53.34	-55.19	-39.66	-31.08	-25.83
Net Income/Loss	3.34% -53.34	-55.19	-39.66	-31.08	-25.83
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	5,488% 59.31	1.0614	55.61	51.87	46.94
Diluted Average Shares	5,488% 59.31	1.0614	55.61	51.87	46.94
Basic Earnings Per Share	11.76% -0.90	-1.02	-0.71	-0.60	-0.55
Diluted Earnings Per Share	11.76% -0.90	-1.02	-0.71	-0.60	-0.55
Common Stock Dividends	-	-	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

GMAB

$20.39

0.34%

RPRX

$36.24

0.27%

SMMT

$23.15

7.69%

INSM

$96.83

0.40%

BNTX

$108.13

0.15%

ONC

$247.47

1.13%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters